Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FX2BW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 12, 2025, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, valued at approximately $49.4K, was issued by the Defense Logistics Agency (DLA) without a set-aside designation. The order is set to be completed by September 3, 2025, with the place of performance located in Park Ridge, Illinois. This delivery order represents a specific purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid through November 2026 that enables the agency to procure pharmaceutical products for military health facilities worldwide.
Entyvio is a biologic medication used to treat inflammatory bowel diseases, and this procurement supports the pharmaceutical supply needs of Department of Defense healthcare systems. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing delivery orders from the DLA for an extensive range of branded and generic prescription drugs, biologics, and medical consumables. The company's continued success in federal contracting reflects its operational capability to distribute specialized pharmaceutical products directly to military medical facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FX2BW?
SPE2DB25FX2BW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FX2BW worth?
The government has obligated $49,449 on SPE2DB25FX2BW.
Is contract SPE2DB25FX2BW an order under another contract?
Yes. SPE2DB25FX2BW is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2BW competed?
The extent of competition for SPE2DB25FX2BW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award